跳至主要内容
临床试验/NCT04912193
NCT04912193已完成不适用

Low Preoperative Antithrombin III Level is Associated With Postoperative Acute Kidney Injury After Liver Transplantation

Asan Medical Center1 个研究点 分布在 1 个国家目标入组 2,395 人开始时间: 2010年1月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
2,395
试验地点
1
主要终点
acute kidney injury

研究概览

简要总结

The reno-protective effect of Antithrombin III (ATIII) has been well-studied in various animal studies; however, little is known about the effect of ATIII on kidney function in patients undergoing liver transplantation (LT). This study aimed to determine the association between preoperative ATIII level and postoperative acute kidney injury (AKI) after LT (post-LT AKI).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Other

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients who underwent either living- or deceased-donor LT (LDLT, DDLT) from January 2010 to January 2018

排除标准

  • patients who underwent re-transplantation
  • patients who were previously diagnosed with end-stage renal disease or Chronic kidney disease
  • patients who were being treated with continuous renal replacement therapy
  • preoperative or postoperative Antithrombin III levels were not available

研究组 & 干预措施

antithrombin III < 50 %

preoperative antithrombin III levels <50%

干预措施: Antithrombin III (Drug)

结局指标

主要结局

acute kidney injury

时间窗: postoperative 7 day

serum creatinine \>0.3 mg/dL within POD 2 or increase by \>1.5 times within POD 7 according to the criteria set by the Kidney Disease: Improving Global Outcomes (KDIGO) classification

次要结局

  • chronic kidney disease(postoperative 3 months)
  • early allograft dysfucion(postoperative 7 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kyoung-Sun Kim

Senior Clinical Fellow

Asan Medical Center

研究点 (1)

Loading locations...

相似试验